Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoid Tumor × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Octreotide 5 Everolimus 4 pasireotide 3 lanreotide 3 ganitumab 2 gallium Ga 68 dotatate 2 cabozantinib 2 Nivolumab 2 Erlotinib Hydrochloride 2 surufatinib 1 pertuzumab 1 nintedanib 1 ibrutinib 1 fosbretabulin 1 conatumumab 1 cixutumumab 1 carfilzomib 1 arginyllysine 1 aflibercept 1 Temozolomide 1 Sunitinib 1 Somatostatin 1 Random Allocation 1 Ramucirumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Capecitabine 1 Bevacizumab 1 Axitinib 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡